Moran Shemesh
Analyst · Wolfe Research. Please proceed with your question
Thank you, Amnon. Thanks for joining the call everyone. Before I begin, please be aware that all my comments on profitability will refer to non-GAAP measurements. The primary exclusion in Mobileye’s non-GAAP numbers is a monetization of intangible assets, which is mainly related to Windows acquisition of Mobileye in 2017. We also exclude stock-based compensation as well as the goodwill impairment that occurred in Q3. Our Q4 results slightly exceeded the Q4 outlook implied by the full year guidance we provided back in October, largely due to higher-than-expected volumes from Chinese OEM, it was down 23% year over year. There isn't much insight to be gained from that comparison as a portion of the meaningful inventory buildup the impact of the first half of 2024 occurred in Q4 of 2023. Q1 will again be an apple to oranges year-over-year comparison given the inventory digestion that occurred in Q1 of 2024 beginning with Q2, the comparison will be more relevant. Gross margin was consistent with expectation and up slightly versus Q3 due to lower percentage of supervision revenue in Q4 versus Q3. Operating expenses without somehow versus Q3 as expected. This is related to the initial impact of the LIDAR unit wind down and increase in military reserve duty, refund some adjustment based on the evaluation of benefited clause and other items that are largely timing related. Turning to guidance, we provided 2025 revenue and adjusted operating income guidance in today's earning release. At the midpoint, we expect $1.75 billion of revenue and $217 million of adjusted operating income. This represents approximately 6% year-over-year revenue growth and more than 10% growth in adjusted operating income. The revenue guidance is based on EyeQ volumes in the range of $32 million to $34 million units. Amnon mentioned, we are assuming the vast majority of supervision units this year are for postal four and expect overall volumes in the low 20,000-unit range at the midpoint. Assuming no expansion into the U.S., I know that for the time being we don't plan on expressly addressing supervision volumes in the near term until we began launching this system on more products with Western OEMs in 2026. We don't expect it to be significant enough to call out and we set expectation low enough that any variances to downside are not material. On the EyeQ volume side, based on our analysis and information from Tier 1, we believe that customer inventories are currently at normal seasonal levels. To give you better insight on our guidance, we thought it will be helpful to provide a bridge from the second half 2024 annualized run rate of 35.6 million units to the mid-point of our 2025 volume outlook of 33 million, which is somewhat below the indications we currently have from our customers. We don't plan to provide this level of detail on a quarterly basis, but think it is helpful as context for our initial 2025 outlook. First of all, some pull forward of volume into Q4 is typical given annual price changes in volume then, we estimate this added about half a million units annualized in Q4 2024, and we are not assuming this occurs again in Q4 2025. We assume 2025, our production of our core OEM customers, which represent about half of industry volume, will be down almost 7% versus 2024 levels, similar to the decrease we saw in 2024 versus 2023. This is meaningfully lower and more conservative than IHS production of minus 4% and would account for about 2.3 million units of reduction. Partly offsetting the assumed production decline. We do expect share gains and ADAS adoption growth from these customers to drive approximately 1.5 million units of growth in 2025 or about 4 points of growth over market. These are not generic expectations, but rather relate to new programs in additional markets with specific OEMs. Regarding seasonality, second-half production at our top customers is typically 2% higher than first half. This would represent almost 1 million units annualized reduction versus the second half runway rate. Finally, regarding the China OEM, we are assuming approximately 0.5 million unit decline as compared to the second half run rate. This is to reflect the volatility we've seen over the last several quarters. Turning to gross margin in 2025, we are assuming about 1.5 points higher than 2024 primarily due to the lower percentage of supervision-related revenue. In terms of operating expenses, we expect about $250 million per quarter during 2025 on average, which is consistent with our comments on the Q3 call where we said the run rate at the same time would be sustained to 2025, versus that Q3 run rate we will see savings from the wind-down of the LIDAR unit. We expect this reduction to be offset by typical employee compensation inflation, as well as our expected military reserve investment. I remind you that headcount-related expenses represent well above half of our OpEx. Other areas of growth, such as AV testing and customer and cloud-related expenses are largely offset by efficiencies within our data labeling activities, as well as expected higher year-over-year engineering year reimbursement on production program spending. In terms of Q1, we expect revenue to be down about 11% versus Q4, which reflects typical seasonality and a bit more than 80% growth year over year against the inventory digestion we experienced in Q1 of 2024. Our revenue expectation for Q1 implies about 25% of the midpoint of our full year revenue guidance. We expect overall gross margin about a hundred basis points higher than Q4 level, and for adjusted operating expenses to be at or slightly lower than the $250 million per quarter I indicated earlier. Operating cash flow in 2024 was well above adjusted net income, even after taking into account capital expenditure of $81 million. Cashflow generation in 2024 was consistent with 2023, despite substantially lower adjusted operating income, reflecting strong management and control of working capital in a variety of areas. Additionally, we anticipate continuing to reduce our strategic reserve of cheap inventory on our balance sheet in 2025. We should support another year of delivering operating cash flow above adjusted net income. Finally, we expect the full-year effective tax rate to be approximately 20%, similar to 2024. Thank you. And we'll now take your questions.